Summit Partners exits Dreampath Diagnostics to Halma
Tuesday, July 7, 2026 · first reported by PE Hub
Summit Partners exits Dreampath Diagnostics, a pathology lab tracking systems provider serving 500+ labs across 50 countries, to Halma.
- Firm
- Summit Partners
- Also named
- Dreampath Diagnostics, Halma
- Asset class
- Private equity
The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.
See an error?
More in Deals
From the same day- Lockheed Martin to acquire Advent-backed Ultra Maritime in $3.45bn dealPrivate Equity Wire
- Sango Capital takes over $458m Kuramo assets via continuation vehiclePrivate Equity Wire
- I Squared to acquire Milestone Environmental from SK CapitalPE Hub
- Wynnchurch-backed Principal Industries acquires GENLED BrandsPE Hub
- Unity Partners buys Meaden & Moore Advisors, expects to do add-onsPE Hub
- Capitol Meridian snaps up national security infrastructure firm Westway EnterprisesPE Hub
Got news? Send it to us →